v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 2,600,342 $ 3,264,429
Accounts receivable 187,830 110,574
Prepaid expenses 250,061 338,660
Other current assets 255,769 343,145
Total Current Assets 3,294,002 4,056,808
Property and equipment, net 4,348,316 4,429,152
Operating lease right-of-use assets 560,610 599,816
Intangible assets, net 317,129 313,747
Total Assets 8,520,057 9,399,523
Current Liabilities    
Accounts payable 3,011,897 2,766,178
Accrued liabilities 3,698,868 3,476,903
Deferred revenue 230,000 230,000
Management and directors' fees payable 54,392 30,086
Current portion of long-term debt 862,475 860,223
Current portion of finance lease liabilities 49,179 46,737
Current portion of operating lease liabilities 224,690 221,755
Current portion of grant repayable 63,750 60,979
Warrant liability 77,848 97,886
Total Current Liabilities 8,273,099 7,790,747
Deferred revenue, net of current portion 22,663,400 22,663,400
Long-term debt, net of current portion 5,532,382 3,952,846
Finance lease liabilities, net of current portion 330,847 328,338
Operating lease liabilities, net of current portion 369,342 410,686
Grant repayable, net of current portion 377,662 361,242
Total Long-Term Liabilities 29,273,633 27,716,512
Total Liabilities 37,546,732 35,507,259
Stockholders' Deficit    
Common Stock Authorized: 175,000,000 shares of common stock, at $0.001 par value per share Issued and outstanding: 100,746,467 shares and 96,097,485 shares, respectively 100,747 96,098
Additional paid-in capital 206,961,962 204,154,994
Accumulated other comprehensive income 131,702 385,631
Accumulated deficit (234,968,102) (229,544,343)
Total VolitionRx limited Stockholders' Deficit (27,773,691) (24,907,620)
Non-controlling interest (1,252,984) (1,200,116)
Total Stockholders' Deficit (29,026,675) (26,107,736)
Total Liabilities and Stockholders' Deficit $ 8,520,057 $ 9,399,523

Source

10-Q PDF
XBRL